FDA
-
-
-
-
-
-
-
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
-
-
-
-
-
-
-
Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
-
-
-
-
-
-
-
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
-
-
-
-
-
-
-
Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
-
-
-
-
-
-
-
Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines
-
-
-
-
-
-
-
Regeneron (REGN): Dupixent Approved in U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
-
-
-
-
-
-
-
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
-
323,147 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

